| C-Type Lectins DC-SIGN and L-SIGN Mediate Cellular Entry by Ebola Virus in cis and in trans CP Alvarez, F Lasala, J Carrillo, O Muñiz, AL Corbí, R Delgado Journal of virology 76 (13), 6841-6844, 2002 | 851 | 2002 |
| A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease SA Danner, A Carr, JM Leonard, LM Lehman, F Gudiol, J Gonzales, ... New England Journal of Medicine 333 (23), 1528-1534, 1995 | 689 | 1995 |
| Evaluation of convalescent plasma for Ebola virus disease in Guinea J Van Griensven, T Edwards, X de Lamballerie, MG Semple, P Gallian, ... New England Journal of Medicine 374 (1), 33-42, 2016 | 650 | 2016 |
| Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection S Mañes, G del Real, RA Lacalle, P Lucas, C Gómez‐Moutón, ... EMBO reports, 2000 | 443 | 2000 |
| Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins Z Yang, R Delgado, L Xu, RF Todd, EG Nabel, A Sanchez, GJ Nabel Science 279 (5353), 1034-1037, 1998 | 347 | 1998 |
| Synthesis of giant globular multivalent glycofullerenes as potent inhibitors in a model of Ebola virus infection A Muñoz, D Sigwalt, BM Illescas, J Luczkowiak, L Rodríguez-Pérez, ... Nature chemistry 8 (1), 50-57, 2016 | 310 | 2016 |
| Lopinavir/ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept pilot clinical … JR Arribas, F Pulido, R Delgado, A Lorenzo, P Miralles, A Arranz, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 40 (3), 280-287, 2005 | 214 | 2005 |
| Filamin-A regulates actin-dependent clustering of HIV receptors S Jiménez-Baranda, C Gómez-Moutón, A Rojas, L Martínez-Prats, E Mira, ... Nature cell biology 9 (7), 838-846, 2007 | 207 | 2007 |
| Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV F Pulido, JR Arribas, R Delgado, E Cabrero, J González-García, ... Aids 22 (2), F1-F9, 2008 | 194 | 2008 |
| Rituximab for high-risk, mature B-cell non-Hodgkin’s lymphoma in children V Minard-Colin, A Aupérin, M Pillon, GAA Burke, DA Barkauskas, ... New England Journal of Medicine 382 (23), 2207-2219, 2020 | 193 | 2020 |
| Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ... Clinical infectious diseases 62 (5), 655-663, 2016 | 189 | 2016 |
| DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist M Thépaut, J Luczkowiak, C Vivès, N Labiod, I Bally, F Lasala, Y Grimoire, ... PLoS pathogens 17 (5), e1009576, 2021 | 172 | 2021 |
| Glycofullerenes inhibit viral infection J Luczkowiak, A Munoz, M Sanchez-Navarro, R Ribeiro-Viana, A Ginieis, ... Biomacromolecules 14 (2), 431-437, 2013 | 167 | 2013 |
| Virus-like glycodendrinanoparticles displaying quasi-equivalent nested polyvalency upon glycoprotein platforms potently block viral infection R Ribeiro-Viana, M Sánchez-Navarro, J Luczkowiak, JR Koeppe, ... Nature communications 3 (1), 1303, 2012 | 161 | 2012 |
| Mannosyl Glycodendritic Structure Inhibits DC-SIGN-Mediated Ebola Virus Infection in cis and in trans F Lasala, E Arce, JR Otero, J Rojo, R Delgado Antimicrobial agents and chemotherapy 47 (12), 3970-3972, 2003 | 158 | 2003 |
| Generation of retroviral vector for clinical studies using transient transfection S Yang, R Delgado, CS Barker, ZY Yang, GJ Nabel, SR King, ... Human gene therapy 10 (1), 123-132, 1999 | 158 | 1999 |
| Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and 2 nucleosides for maintenance therapy of HIV: 96-week analysis JR Arribas, R Delgado, A Arranz, R Muñoz, J Portilla, J Pasquau, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (2), 147-152, 2009 | 145 | 2009 |
| Genetic barrier to resistance for dolutegravir. JM Llibre, F Pulido, F García, M Garcia Deltoro, JL Blanco, R Delgado AIDS reviews 17 (1), 2015 | 136 | 2015 |
| SARS-CoV-2 infection in health care workers in a large public hospital in Madrid, Spain, during March 2020 MD Folgueira, C Muñoz-Ruipérez, MÁ Alonso-López, R Delgado MedRxiv, 2020.04. 07.20055723, 2020 | 130 | 2020 |
| Multivalent glycosylated nanostructures to inhibit Ebola virus infection BM Illescas, J Rojo, R Delgado, N Martín Journal of the American Chemical Society 139 (17), 6018-6025, 2017 | 127 | 2017 |
Roger Paredes, MD, PhDDepartment of Infectious Diseases & irsiCaixa AIDS Research Institute, Hospital Germans Trias i在 irsicaixa.es 的电子邮件经过验证
